Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Background/AimsChronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the safety and efficacy of combination therapy with peginterferon α-2a plus ribavirin for CHC in hemophilia.Met...

Full description

Bibliographic Details
Main Authors: Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2015-06-01
Series:Clinical and Molecular Hepatology
Subjects:
Chronic hepatitis C
Hemophilia
Peginterferon
Ribavirin
Online Access:http://e-cmh.org/upload/pdf/cmh-21-125.pdf

Similar Items

Similar Items